Urgent Need
In the current global situation, Latin America, especially Brazil, has vast potential for conducting clinical studies due to its population diversity and growing healthcare infrastructure. However, the region faces significant challenges that limit the full realization of this potential, including a lack of standardization among research centers, variability in the quality and capacity to execute clinical studies, and inefficiencies in regulatory and operational processes.
There Are Relevant Problems
-
Lack of Lasting Relationships: The transience in relationships between the research promoter and the sites results in a high volume of rework on the research centers' side, draining part of their energy that should be dedicated mainly to recruiting new participants and data quality generated.
-
Inequality in the Capacity and Quality of Research Sites: There are wide disparities in the infrastructure, experience and quality of research centers, resulting in inconsistencies in the results of clinical studies and the trust of sponsors.
-
Complex and Slow Regulatory Processes: The lack of harmonization and efficiency in regulatory processes delays the start of studies and increases operational costs.
-
Low Volume of Clinical Studies: Compared to other regions, Latin America, especially Brazil, still participates in a relatively low number of global clinical studies.
-
Increased Global Competition: Other regions are increasing their investments in clinical research, which puts Latin America at a competitive disadvantage without significant improvements.
And Achieve a Common Purpose
Through information, facts and data, the sites participating in our benchmarking initiative will have a clear view of the situation in the clinical research sector. This understanding will allow them to implement strategic initiatives internally, and in collaboration with sponsors, that will transform the sector. Equipped with detailed benchmarks, the sites will be able to identify areas for improvement, adopt best practices and position themselves as leaders of excellence in clinical trials in Latin America. Together, we can drive a revolution in the quality and efficiency of clinical research in the region.
What Drives the Decision to Challenge the Status Quo
-
Missed Opportunities: Potential high-impact clinical studies are being diverted to other regions with similar infrastructure and faster regulatory processes.
-
High Opportunity Cost: Research sites lose potential revenue and investment capacity.
Global Competitive Position: Placing Latin America as a competitive and reliable region for carrying out global clinical studies.
03
Greater Volume of Clinical Studies: Significant increase in the number of studies conducted in the region, with greater participation from local research centers.
01
Economic and Scientific Growth: Attracting investments and developing local capabilities, contributing to the economic and scientific growth of the region.
02
To Generate Benefits for Everyone
Locations
Detailed information about the Institutions
Experience
Access to experience level
Staffing
Information regarding current capabilities
KPIs
Relevant performance indicators